Behavioral and Immune Changes in V-Ha-ras Transgenic Mice

References

• Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 1987; 49: 465
   PubMed Web of Science ®Google Scholar
• Marshall M. S. Ras target proteins in eukaryotic cells. FASEB J. 1995; 9: 1311
   PubMed Web of Science ®Google Scholar
• Hanahan D. Dissecting multistep tumorigenesis in transgenic mice. Ann. Rev. Genet. 1988; 22: 479
   PubMed Web of Science ®Google Scholar
• Hanahan D. Transgenic mice as probes into complex systems. Science 1989; 246: 1265
   PubMed Web of Science ®Google Scholar
• Chen G.-J., Colombo L. L., Lopez M. C., Watson R. R. Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene bearing mice. Cancer Lett. 1993; 74: 147
   PubMedGoogle Scholar
• Chen G., Colombo L. L., Lopez M. C., Watson R. R. Effect of ethanol and cocaine treatment on the immune system of v-Ha-ras transgenic mice. Int. J. Immunopharmacol. 1996; 18: 251
   PubMedGoogle Scholar
• Smith R. S. The Macrophage theory of depression. Med. Hypotheses 1991; 35: 298
   PubMed Web of Science ®Google Scholar
• Lieber C. S., DeCarli L. M. Liquid diet technique of ethanol administration: Update. Alcohol Alcoholism 1989; 24: 197
   PubMed Web of Science ®Google Scholar
• Lopez M. C., Colombo L. L., Huang D. S., Wang Y., Watson R. R. Modification of thymic cell subsets induced by long-term cocaine administration during murine retroviral infection producing AIDS. Clin. Immunol. Immunopathol. 1992; 65: 45
   PubMedGoogle Scholar
• Watzl B., Lopez M., Shahbazian M., Chen G., Colombo L. L., Huang D., Way D., Watson R. R. Diet and ethanol modulate immune responses in young C57BL/6 mice. Alcohol. Clin. Exp. Res. 1993; 17: 623
   PubMed Web of Science ®Google Scholar
• National Research Council. Nutritional requirements of the mouse. Requirements of laboratory animals no. 10 rev ed 3. National Academy of Sciences, Washington, DC 1978; 38
   Google Scholar
• Weed J. L., Lane M. A., Speer D. L., Ingram D. K. Activity measures in rhesus monkeys on long-term calorie restriction. Physio. Behav. 1997; 62: 97
   PubMed Web of Science ®Google Scholar
• Fernandez S., Gonzalez C., Patterson A. M. Oil enriched diets and behavioral parameters in rats' recovery from early undernutrition. Physiol. Behav. 1997; 62: 113
   PubMedGoogle Scholar
• DeWille J. W., Waddell K., Steinmeyer C., Farmer S. J. Dietary fat promotes mammary tumorigenesis in MMTV/v-Ha-ras transgenic mice. Cancer Lett. 1993; 69: 59
   PubMed Web of Science ®Google Scholar
• Fernandes G., Chandrasekar B., Troyer D. A., Venkatraman T. J., Good R. A. Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc. Natl. Acad. Sci. USA 1995; 92: 6494
   PubMed Web of Science ®Google Scholar
• Harkany T., Sasvari M., Nyakas C. Chronic ethanol ingestion-induced changes in open-field behavior and oxidative stress in the rat. Pharmacol. Biochem. Behav. 1997; 58: 195
   PubMedGoogle Scholar
• Derogatis L. R., Morrow G. R., Fetting J., Penman D., Pisetsky S., Schmale A. M., Henricks M., Carnicke L. M. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751
   PubMed Web of Science ®Google Scholar
• Perskey V. W., Kempthorne-Rawson J., Shekelle R. B. Personality and risk of cancer: 20-year followup of the Western Electric study. Psychosom. Med. 1987; 49: 435
   PubMedGoogle Scholar
• Kaplan G. A., Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda county study. J. Behav. Med. 1988; 11: 1
   PubMed Web of Science ®Google Scholar
• Stavraky K. M. Psychological factors in the outcome of cancer. J. Psychosom. Res. 1968; 12: 251
   Web of Science ®Google Scholar
• Von Horsten S., Exton M. S., Voge J., Schult M., Nagel E., Schmidt R. E., Westermann J., Schedlowski M. Cyclosporine A affects open field behavior in DA rats. Pharmacol. Biochem. Behav. 1998; 60: 71
   PubMedGoogle Scholar
• Watkins L. R., Goehler L. E., Relton J., Brewer M. T., Maier S. F. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 1995; 692: 244
   PubMedGoogle Scholar
• Dunn A. J., Swiergiel A. H. The role of cytokines in infection-related behavior. Ann. N. Y. Acad. Sci. 1998; 840: 577
   PubMedGoogle Scholar
• Di Giovane F. S., Duff G. W. Interleukin 1: the first interleukin. Immunol. Today 1990; 11: 13
   PubMedGoogle Scholar
• Dinarello C. A., Thompson R. C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 1991; 12: 404
   PubMedGoogle Scholar
• Arend W. P., Malyak M., Guthridge C. J., Gabay C. Interleukin-1 receptor antagonist: role in biology. Ann. Rev. Immunol. 1998; 16: 27
   PubMed Web of Science ®Google Scholar
• Bluthe R. M., Michaud B., Kelley K. W., Dantzer R. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. NeuroReport 1996; 7: 1485
   PubMed Web of Science ®Google Scholar
• Maes M., Bosmans E., Suy E., Vandervorst C., DeJonckheere C., Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 1991; 84: 379
   PubMedGoogle Scholar
• Grenfell S., Smithers N., Miller K., Solari R. Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem. J. 1989; 264: 813
   PubMed Web of Science ®Google Scholar
• Lilic D., Kukic Z., Pejnovic N., Dujic A. Interleukin-1 in vivo modulates trauma-induced immunosuppression. Eur. Cytokine Netw. 1990; 1: 149
   PubMedGoogle Scholar
• Dawson J., Edwards J. C., Sedgwick A. D., Lees P. IL-1α inhibits lymphocyte migration into a site of chronic inflammation. Immunol. Lett. 1991; 30: 319
   PubMedGoogle Scholar